Home > Insider Trading > Filing (0001209191-14-024779)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1593034	Endo International Plc	ENDP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263102	John Delucca	C/O Endo International Plc No. 33 Fitzwilliam Square Dublin L2 2		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2014-04-01	10,384	$16.80	31,980	No	4	M	Direct
Ordinary Shares	Disposition	2014-04-01	10,384	$68.46	21,596	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	2007 Stock Incentive Plan Stock Options (NQ)	Disposition	2014-04-01	10,384	$0.00	10,384	$16.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-03-12	No	4	M	Direct

Footnotes

On March 10, 2014, in connection with his personal financial planning, Mr. Delucca placed 25,242 of the shares underlying his stock options into a 10b5-1 pre-set selling program (the "Delucca Pre-Set Selling Program"). The options exercised and the shares sold above were sold pursuant to the Delucca Pre-Set Selling Program, which leaves 14,858 remaining shares (underlying options) in the current Delucca Pre-Set Selling Program. The Delucca Pre-Set Selling Program's initial termination date is the earlier of December 31, 2014 or the date all shares under the program are sold.
This represents the average price at which Mr. Delucca's ordinary shares were sold on April 1, 2014.
Mr. Delucca's stock options that were granted under the 2007 Stock Incentive Plan on March 12, 2009 were generally exercisable 25% per year on each of March 12, 2010, March 12, 2011, March 12, 2011, and March 12, 2013.
These securities were granted to Mr. Delucca in 2009 in consideration of his services on the Endo Health Solutions Inc. Board of Directors.